Abstract
Metaplastic carcinoma of the breast is a rare form of breast cancer and has an uncertain prognostic significance. Cases from Asian countries have never been reported in the English literature. Between 1983 and 1998, we encountered 8 cases in our institution. There were 7 women and one man with a median age of 52.5 (37-73) years. Pathologic diagnosis included three poorly-differentiated adenosquamous carcinomas, two adenocarcinomas with spindle cell metaplasia, two matrix-producing carcinomas and one carcinosarcoma. Estrogen receptor was positive in 2 (25%) patients. Local recurrence or distant metastasis developed in 3 patients within one year of initial treatment. With a mean follow-up of 81 months (range, 19-183 months), 5 patients were disease-free at the time of this report. Interestingly, two of our patients had presented with huge-sized inflammatory breast cancer and were refractory to neo-adjuvant chemotherapy, but enjoyed an unexpected long disease-free survival after mastectomy. Although the clinical course of our patients appeared in general similar to that of the Western series, the two patients with inflammatory breast carcinoma ran a very unusual course, which may deserve further characterization.
MeSH terms
-
Adenocarcinoma / chemistry
-
Adenocarcinoma / pathology*
-
Adenocarcinoma / therapy
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor / analysis
-
Breast Neoplasms / chemistry
-
Breast Neoplasms / epidemiology
-
Breast Neoplasms / pathology*
-
Breast Neoplasms / therapy
-
Breast Neoplasms, Male / chemistry
-
Breast Neoplasms, Male / pathology
-
Breast Neoplasms, Male / therapy
-
Carcinoma, Adenosquamous / chemistry
-
Carcinoma, Adenosquamous / pathology
-
Carcinoma, Adenosquamous / therapy
-
Carcinoma, Ductal, Breast / chemistry
-
Carcinoma, Ductal, Breast / pathology
-
Carcinoma, Ductal, Breast / therapy
-
Carcinosarcoma / chemistry
-
Carcinosarcoma / pathology
-
Carcinosarcoma / therapy
-
Chemotherapy, Adjuvant
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Epirubicin / administration & dosage
-
Estrogens
-
Female
-
Fluorouracil / administration & dosage
-
Humans
-
Inflammation
-
Lymphatic Metastasis
-
Male
-
Mastectomy
-
Metaplasia
-
Middle Aged
-
Neoplasm Metastasis
-
Neoplasm Proteins / analysis
-
Neoplasms, Hormone-Dependent / chemistry
-
Neoplasms, Hormone-Dependent / pathology
-
Neoplasms, Hormone-Dependent / therapy
-
Progesterone
-
Receptors, Estrogen / analysis
-
Receptors, Progesterone / analysis
-
Retrospective Studies
-
Taiwan / epidemiology
-
Treatment Outcome
Substances
-
Biomarkers, Tumor
-
Estrogens
-
Neoplasm Proteins
-
Receptors, Estrogen
-
Receptors, Progesterone
-
Epirubicin
-
Progesterone
-
Cyclophosphamide
-
Fluorouracil